SF,

I too hear your frustration and have been invested in RVX for 8 years now, seen the highs and low, a definite investment soap opera, That being said, I think I have been told that the time it takes for a biotech company to go from pre clinical to FDA approval for any drug is close to 15 to 20 years, What always attracted to RVX was the groundbreak science not the managment .

I think most of us have invested too early but hindsight is 20 20, Obviously If I knew today what I didn't know 8 years ago, I would have waited afer ASSURE trial failure and loaded tons tons of shares at .20. We have come a long long way since that day and have moved forward and close to the end game , That what this investment is a binary situation, either it works get the MAce results and gets EMA/ FDA approval or it doesn't, What would be the share price with succesful results and FDA approval $18 $20 $50?? I think I am willing to wait it out , The odds are tipped in our favour for those in the know with the Post hoc analysis,

I am all in